Brain and Behavior

Papers
(The H4-Index of Brain and Behavior is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Longitudinal changes in anxiety and psychological distress, and associated risk and protective factors during the first three months of the COVID‐19 pandemic in Germany108
Neuropsychological deficits in patients with cognitive complaints after COVID‐1994
Gender differences in emotional response to the COVID‐19 outbreak in Spain85
Cognitive frailty as a predictor of adverse outcomes among older adults: A systematic review and meta‐analysis76
Molecular links between endocrine, nervous and immune system during chronic stress73
Treatment for comorbid depressive disorder or subthreshold depression in diabetes mellitus: Systematic review and meta‐analysis68
Variability of EEG electrode positions and their underlying brain regions: visualizing gel artifacts from a simultaneous EEG‐fMRI dataset62
Burnout, depersonalization, and anxiety contribute to post‐traumatic stress in frontline health workers at COVID‐19 patient care, a follow‐up study53
Gut microbiota variations in patients diagnosed with major depressive disorder—A systematic review51
Psychometric properties of Structured Clinical Interview for DSM‐5 Disorders‐Clinician Version (SCID‐5‐CV)51
Facial palsy during the COVID‐19 pandemic49
A mediating role for mental health in associations between COVID‐19‐related self‐stigma, PTSD, quality of life, and insomnia among patients recovered from COVID‐1949
Cerebral blood flow impairment and cognitive decline in heart failure48
Fear of hypoglycemia—An underestimated problem45
The burden of epilepsy and unmet need in people with focal seizures44
Pyroptosis executive protein GSDMD as a biomarker for diagnosis and identification of Alzheimer’s disease43
Profiling COVID‐related experiences in the United States with the Epidemic‐Pandemic Impacts Inventory: Linkages to psychosocial functioning41
Study on the neuroprotective effects of Genistein on Alzheimer’s disease40
Prognostic prediction of hypertensive intracerebral hemorrhage using CT radiomics and machine learning39
Predictors of response to erenumab after 12 months of treatment37
Schizophrenia outcomes in the 21st century: A systematic review35
Associations between coronary heart disease and risk of cognitive impairment: A meta‐analysis34
Personality profile of individual sports champions33
High fibrinogen‐to‐albumin ratio is associated with hemorrhagic transformation in acute ischemic stroke patients33
Cognitive decline and brainstem hypometabolism in long COVID: A case series31
Separating scale‐free and oscillatory components of neural activity in schizophrenia30
Is Alzheimer's disease an infectious neurological disease? A review of the literature30
The GLP‐1/GIP dual‐receptor agonist DA5‐CH inhibits the NF‐κB inflammatory pathway in the MPTP mouse model of Parkinson's disease more effectively than the GLP‐1 single‐receptor agonist NLY0130
Literacy and stigma of suicide in Bangladesh: Scales validation and status assessment among university students29
Improvement of poststroke cognitive impairment by intermittent theta bursts: A double‐blind randomized controlled trial29
Factors affecting Pakistani young adults’ intentions to uptake COVID‐19 vaccination: An extension of the theory of planned behavior29
0.021728992462158